Evident Vascular

San Jose, United States Founded: 2021 • Age: 5 yrs
AI-enabled catheter-based ultrasound platforms are developed for vascular therapy.

About Evident Vascular

Evident Vascular is a Healthcare company based in San Jose (United States) founded in 2021 by Patrick Phillips, Howard Rosen, and Danielo Piazza. AI-enabled catheter-based ultrasound platforms are developed for vascular therapy. Evident Vascular has raised $35 million across 2 funding rounds from investors including ShangBay Capital and Vensana Capital. Its chief executive, as recorded, is Howard Rosen. Evident Vascular offers products and services including IVUS Platform. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is Evident Vascular, Inc. Its competitors include AIdoc, Lantheus and Vista.ai; 2 of its 3 listed competitors have raised funding.

Company details

Evident Vascular was founded in 2021 and is headquartered in San Jose, United States. AI-enabled catheter-based ultrasound technology is developed by the company within the medical device sector. An intravascular ultrasound (IVUS) platform powered by AI is provided to support image-guided therapy in peripheral vascular procedures. Operations emphasize tools for clinical applications in vascular interventions, with a focus on United States-based development and deployment.

  • Headquarters San Jose, United States
  • Founders Patrick Phillips, Howard Rosen, Danielo Piazza
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website evidentvascular.com
  • Social LinkedIn
  • Legal Name Evident Vascular, Inc.
Key Metrics

Products & Services of Evident Vascular

Evident Vascular offers a comprehensive portfolio of products and services, including IVUS Platform.

IVUS Platform
Medical Imaging

AI-driven system for enhanced ultrasound in vascular disease interventions

Funding Insights of Evident Vascular

Evident Vascular has successfully raised a total of $35M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $35M
  • Total Rounds 2
  • First Round $35M

    (Oct 2023)

  • Investors Count 2

All 2 funding rounds of Evident Vascular with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2025Series B––
Oct 2023$35MSeries A–Vensana Capital
–
Valuation history

2 investors in total: 2 institutional.

Investors in Evident Vascular

Evident Vascular has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include ShangBay Capital and Vensana Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
shangbaycapital.com
Investments in medical technology are made by Vensana Capital.
vensanacap.comMinneapolis, United States
Premium access

Investor details for Evident Vascular

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Evident Vascular

7 people are tracked at Evident Vascular (4 in leadership, 3 in team).

NameRoleGroup
Patrick Phillips
Co-Founder & CTOLeadership
Howard Rosen
Co-Founder & CEOLeadership
Danielo Piazza
Co-Founder & CPOLeadership
Adam Darmstadt
Director, Software DevelopmentLeadership
Terry Simpson
Principal Hardware EngineerTeam
Luke Reimer
Senior Quality EngineerTeam
Adlai Shawareb
Technical Program Manager, SoftwareTeam
Premium access

Complete people profiles for Evident Vascular

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Evident Vascular

3 dated milestones of Evident Vascular across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Evident Vascular is founded.
  2. Funding First funding round of $35.0M.
  3. Funding Latest funding round, Series B,.

Competitors of Evident Vascular

Evident Vascular has 3 listed competitors in our database, 2 of them funded. They include AIdoc, Lantheus and Vista.ai.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
aidoc.com2016New York, United States$424.5M
AI-based single-screen system is provided to streamline medical imaging.
lantheus.com2008Billerica, United States834
Developer of diagnostic imaging agents and targeted therapeutics
vista.ai2012Palo Alto, United States$8.7M13
AI-guided software is utilized to automate MRI exams for clinicians.
Premium access

Detailed competitors of Evident Vascular

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Evident Vascular

The website of Evident Vascular (evidentvascular.com) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▲ 15.7% vs previous month

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Evident Vascular (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Evident Vascular

Premium access

Complete news archive for Evident Vascular

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Evident Vascular

Evident Vascular was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Evident Vascular is headquartered in San Jose, United States. It is registered at San Jose, California, United States.

Howard Rosen is the CEO of Evident Vascular, as recorded in our data. They have also founded this company.

Evident Vascular is a funded company, having raised a total of $35M across 2 funding rounds to date. The company's 1st funding round was a Series A of $35M, raised on Oct 2023.

Evident Vascular was founded in 2021 and is headquartered in San Jose, United States. AI-enabled catheter-based ultrasound technology is developed by the company within the medical device sector. An intravascular ultrasound (IVUS) platform powered by AI is provided to support image-guided therapy in peripheral vascular procedures. Operations emphasize tools for clinical applications in vascular interventions, with a focus on United States-based development and deployment.

Evident Vascular's top competitors include AIdoc, Vista.ai and Lantheus.

Evident Vascular offers IVUS Platform.

Evident Vascular has 2 investors. Key investors include ShangBay Capital, and Vensana Capital.

Evident Vascular operates through Evident Vascular, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available